Corporate Governance

Scientific Advisors

PORxin Platform

Scientific Conferences

Scientific Publications

BPH	Prostate Cancer

PRX302

PRX321

Clinical Trials

Links

Events Calendar

Analyst Coverage

News	Media Coverage

About Vancouver

Current Opportunities

Current Opportunities

NO CURRENT OPENINGS

What's New

February 4, 2010
Protox Announces Private Placement

January 11, 2010
Protox Announces Positive Phase 2B BPH Results

November 16, 2009
Protox Reports 2009 Third Quarter Results

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

Stock Quote

	LAST TRADE:	$0.53
	TRADE TIME:	3:04PM EST
	CHANGE:	$-0.02 (-3.64%)
	PREV CLOSE:	$0.55
	OPEN:	$0.53
	BID:	$0.54
	ASK:	$0.55